K certainly works in the context of reactivating p53 safely in a large % of patients. That itself is a major breakthrough in oncology and will be accepted anywhere. When Dana-Farber finally decides to let the cat out of the bag, we'll get some major attentions.

Quote:

---

I wonder if people realize that the fact that they say they have submitted it means:
1) It works
2) They are confident of the article being accepted, or they wouldn't have PR'ed it

---